Clinical Trial Update: Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR) [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluating the safety and feasibility of using the Chartis System in patients with heterogeneous emphysema prior to endobronchial lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterogeneous Emphysema

Drugs mentioned

• Chartis System

Snippet

Sponsor: Pulmonx Corporation | Conditions: Heterogeneous Emphysema | Phase 1, Phase 2 | Status: COMPLETED